Guochuan E. Tsai

Best Publications

• Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis

  Jeffrey D. Rothstein;Guochuan Tsai;Ralph W. Kuncl;Lora Clawson

  850
  Citations

• D-serine added to antipsychotics for the treatment of schizophrenia

  Guochuan Tsai;Pinchen Yang;Li-Chen Chung;Nicholas Lange

  823
  Citations

• Glutamatergic Mechanisms in Schizophrenia

  Guochuan Tsai;Joseph T. Coyle

  764
  Citations

• Central nervous pathway for acupuncture stimulation: localization of processing with functional MR imaging of the brain--preliminary experience.

  Ming-Ting Wu;Jen-Chuen Hsieh;Jing Xiong;Chien-Fang Yang;Chien-Fang Yang

  644
  Citations

• Abnormal excitatory neurotransmitter metabolism in schizophrenic brains

  Guochuan Tsai;Lucius A. Passani;Barbara S. Slusher;Ruth Carter

  603
  Citations

• Converging Evidence of NMDA Receptor Hypofunction in the Pathophysiology of Schizophrenia

  Joseph T. Coyle;Joseph T. Coyle;Guochuan Tsai;Guochuan Tsai;Donald Goff

  542
  Citations

• The Glutamatergic Basis of Human Alcoholism

  Guochuan Tsai;David R. Gastfriend;Joseph T. Coyle

  534
  Citations

• A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia.

  Donald C. Goff;Guochuan Tsai;James Levitt;Edward Amico

  527
  Citations

• D-serine added to antipsychotics for the treatment of schizophrenia

  Unknown

  527
  Citations

• N-acetylaspartate in neuropsychiatric disorders.

  Guochuan Tsai;Joseph T. Coyle

  518
  Citations

• The Role of Glutamatergic Neurotransmission in the Pathophysiology of Alcoholism

  Guochuan Tsai;Joseph T. Coyle

  495
  Citations

• Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to antipsychotics for the treatment of schizophrenia.

  Guochuan Tsai;Hsien-Yuan Lane;Pinchen Yang;Mian-Yoon Chong

  456
  Citations

• Dose-finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia.

  D. C. Goff;Guochan Tsai;D. R. Manoach;J. T. Coyle

  353
  Citations

• Sarcosine or D-Serine Add-on Treatment for Acute Exacerbation of Schizophrenia: A Randomized, Double-blind, Placebo-Controlled Study

  Hsien-Yuan Lane;Yue-Cune Chang;Yi-Ching Liu;Chih-Chiang Chiu

  338
  Citations

• Strategies to Enhance N-Methyl-D-Aspartate Receptor-Mediated Neurotransmission in Schizophrenia, a Critical Review and Meta-Analysis

  Guochuan E Tsai;Pao-Yen Lin

  315
  Citations

• D-serine added to clozapine for the treatment of schizophrenia.

  Guochuan E. Tsai;Pinchen Yang;Li-Chen Chung;I-Ching Tsai

  312
  Citations

• The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia

  Joseph T. Coyle;Guochuan Tsai

  305
  Citations

• Markers of Glutamatergic Neurotransmission and Oxidative Stress Associated With Tardive Dyskinesia

  Guochuan Tsai;Donald C. Goff;Robert W. Chang;James Flood

  305
  Citations

• Add-on Treatment of Benzoate for Schizophrenia: A Randomized, Double-blind, Placebo-Controlled Trial of d-Amino Acid Oxidase Inhibitor

  Hsien-Yuan Lane;Ching-Hua Lin;Michael F. Green;Michael F. Green;Gerhard Hellemann

  266
  Citations

• Increased Glutamatergic Neurotransmission and Oxidative Stress After Alcohol Withdrawal

  G. E. Tsai;P. Ragan;R. Chang;Shaw Chen

  264
  Citations